SAGE Open Medical Case Reports (Mar 2023)

Imiquimod-induced bullous pemphigoid: A case report

  • Heidi Oi-Yee Li,
  • Michael Aw,
  • Steven J Glassman

DOI
https://doi.org/10.1177/2050313X231164222
Journal volume & issue
Vol. 11

Abstract

Read online

A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol ointment, prednisone and methotrexate, with eventual disease control. He had a severe disease course. Bullous pemphigoid is usually idiopathic, but can be induced by skin trauma, as well as by several medications; this is the first report of imiquimod as a trigger. Imiquimod is a toll-like receptor 7 agonist that induces cellular apoptosis and recruits pro-inflammatory cytokines including tumour necrosis factor-alpha and interferon-alpha, which have been implicated in autoimmunity. This case highlights an unusual but severe adverse effect from topical imiquimod.